A day after a U.S. House committee, on a party-line vote, advanced two bills to reauthorize emergency preparedness programs, the Senate Health, Education, Labor and Pensions (HELP) Committee voted 17-3 July 20 to send its bipartisan reauthorization of the Pandemic and All Hazards Preparedness Act to the Senate floor with a do-pass recommendation.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astellas, Cel-Sci, Emmaus, Gilead, Scisparc.
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Arrivent, Bluebird, Coherus, Crispr, Frequency Therapeutics, Innocare, Korro Bio, KSQ, Nymox, Roche, Superior Biologics, Vertex.
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Biosenic, BMC, Camp4, Elsie, FSD, Fulcrum, Genethon, GSK, Hillstream, Innovent, Maxcyte, Melinta, Novartis, Novavax, Novo Nordisk, Nymox, Paratek, Remegen, Vittoria.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Iaso, Mediwound, Moderna, Nevakar, Injectables, Skyline, Systimmune, Zealand.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adicet, Aldeyra, Aveo, Bavarian Nordic, Biorestorative, Bioxytran, Black Diamond, Cassava, Edgewise, Eli Lilly, Freya, Harpoon, Idorsia, Inozyme, Lobe, Meiragtx, Minervax, Nkarta, Regulus, Sanofi.
Eubiologics Co. Ltd. said it would file for regulatory approval for its COVID-19 vaccine called Eucorvac-19 in the Philippines, after announcing positive interim phase III trial results on June 27.
RSS
